Slam 200 mg filmom obložene tablete
| Name | Slam 200 mg filmom obložene tablete |
|---|---|
| Former Name | Sorafenib JGL 200 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-836221346 |
| Active Substance | sorafenibtosilat |
| Composition | jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku sorafenibtosilata) |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Pharmacare Premium Ltd., Birzebbugia, Malta
Genepharm S.A., Pallini Attiki, Grčka |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 24.03.2022 |
| MA Period of Validity | 24.03.2027 |
| Classification Number | UP/I-530-09/21-01/55 |
| Registration Number | 381-12-01/154-22-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EX02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
